Compare
Booz Allen Hamilton Holding Corp vs FTI Consulting, Inc vs Astrana Health, Inc. vs ICF International, Inc.
| Latest fiscal year | Booz Allen Hamilton Holding Corp BAH | FTI Consulting, Inc FCN | Astrana Health, Inc. ASTH | ICF International, Inc. ICFI |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $11.22B | $3.79B | $3.18B | $1.87B |
| Revenue growth (YoY) | -6.4% | +2.4% | +56.4% | -7.3% |
| Gross margin | 52.7% (computed) | 32.1% | n/a | 37.2% (computed) |
| Operating margin | 9.2% | 10.3% | 2.5% | 7.8% |
| Net margin | 7.6% | 7.1% | 0.7% | 4.9% |
| Net income | $851.00M | $270.87M | $22.49M | $91.59M |
| EPS (Diluted) | $6.90 | $8.24 | $0.46 | $4.95 |
| Operating cash flow | $1.04B | $152.13M | $114.60M | $141.87M |
| Free cash flow | $951.00M | $93.60M | $104.49M | $120.21M |
| Cash & equivalents | $728.00M | $265.09M | $429.47M | $5.30M |
| Total assets | $7.12B | $3.49B | $2.22B | $2.05B |
| Total liabilities | $6.01B | $1.76B | $1.66B | $1.02B |
| Shareholders' equity | $1.10B | $1.73B | $779.29M | $1.03B |
| Return on year-end equity | 77.0% | 15.6% | 2.9% | 8.9% |
| Shares outstanding | 120.34M | 30.86M | 48.89M | 18.25M |
Revenue, most recent five fiscal years
| Fiscal year | Booz Allen Hamilton Holding Corp | FTI Consulting, Inc | Astrana Health, Inc. | ICF International, Inc. |
|---|---|---|---|---|
| Latest | $11.22B Ended 2026-03-31 | $3.79B Ended 2025-12-31 | $3.18B Ended 2025-12-31 | $1.87B Ended 2025-12-31 |
| 1 year earlier | $11.98B Ended 2025-03-31 | $3.70B Ended 2024-12-31 | $2.03B Ended 2024-12-31 | $2.02B Ended 2024-12-31 |
| 2 years earlier | $10.66B Ended 2024-03-31 | $3.49B Ended 2023-12-31 | $1.39B Ended 2023-12-31 | $1.96B Ended 2023-12-31 |
| 3 years earlier | $9.26B Ended 2023-03-31 | $3.03B Ended 2022-12-31 | $1.14B Ended 2022-12-31 | $1.78B Ended 2022-12-31 |
| 4 years earlier | $8.36B Ended 2022-03-31 | $2.78B Ended 2021-12-31 | $773.91M Ended 2021-12-31 | $1.55B Ended 2021-12-31 |